Literature DB >> 29684457

α4-GABAA receptors of hippocampal pyramidal neurons are associated with resilience against activity-based anorexia for adolescent female mice but not for males.

Yi-Wen Chen1, Hannah Actor-Engel1, Chiye Aoki2.   

Abstract

Activity-based anorexia (ABA) is an animal model of anorexia nervosa, a mental illness with highest mortality and with onset that is most frequently during adolescence. We questioned whether vulnerability of adolescent mice to ABA differs between sexes and whether individual differences in resilience are causally linked to α4βδ-GABAAR expression. C57BL6/J WT and α4-KO adolescent male and female mice underwent ABA induction by combining wheel access with food restriction. ABA vulnerability was measured as the extent of food restriction-evoked hyperactivity on a running wheel and body weight losses. α4βδ-GABAAR levels at plasma membranes of pyramidal cells in dorsal hippocampus were assessed by electron microscopic immunocytochemistry. Temporal patterns and extent of weight loss during ABA induction were similar between sexes. Both sexes also exhibited individual differences in ABA vulnerability. Correlation analyses revealed that, for both sexes, body weight changes precede and thus are likely to drive suppression of wheel running. However, the suppression was during the food-anticipatory hours for males, while for females, suppression was delayed by a day and during food-access hours. Correspondingly, only females adaptively increased food intake. ABA induced up-regulation of α4βδ-GABAARs at plasma membranes of dorsal hippocampal pyramidal cells of females, and especially those females exhibiting resilience. Conversely, α4-KO females exhibited greater food restriction-evoked hyperactivity than WT females. In contrast, ABA males did not up-regulate α4βδ-GABAARs, did not exhibit genotype differences in vulnerability, and exhibited no correlation between plasmalemmal α4βδ-GABAARs and ABA resilience. Thus, food restriction-evoked hyperactivity is driven by anxiety but can be suppressed through upregulation of hippocampal α4βδ-GABAARs for females but not for males. This knowledge of sex-related differences in the underlying mechanisms of resilience to ABA indicates that drugs targeting α4βδ-GABAARs may be helpful for treating stress-induced anxiety and anorexia nervosa of females but not males.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anorexia nervosa; Anxiety; Electron microscopic immunocytochemistry; Exercise; Food restriction; GABRA4; Hippocampus; Resilience; Sex difference

Year:  2018        PMID: 29684457      PMCID: PMC6197931          DOI: 10.1016/j.mcn.2018.04.008

Source DB:  PubMed          Journal:  Mol Cell Neurosci        ISSN: 1044-7431            Impact factor:   4.314


  74 in total

1.  A critical role for alpha4betadelta GABAA receptors in shaping learning deficits at puberty in mice.

Authors:  Hui Shen; Nicole Sabaliauskas; Ang Sherpa; André A Fenton; Armin Stelzer; Chiye Aoki; Sheryl S Smith
Journal:  Science       Date:  2010-03-19       Impact factor: 47.728

2.  An osmium-free method of epon embedment that preserves both ultrastructure and antigenicity for post-embedding immunocytochemistry.

Authors:  K D Phend; A Rustioni; R J Weinberg
Journal:  J Histochem Cytochem       Date:  1995-03       Impact factor: 2.479

3.  Considering Sex as a Biological Variable Will Be Valuable for Neuroscience Research.

Authors:  Rebecca M Shansky; Catherine S Woolley
Journal:  J Neurosci       Date:  2016-11-23       Impact factor: 6.167

4.  A sex difference in circadian food-anticipatory rhythms in mice: Interaction with dopamine D1 receptor knockout.

Authors:  Mateusz Michalik; Andrew D Steele; Ralph E Mistlberger
Journal:  Behav Neurosci       Date:  2015-06       Impact factor: 1.912

5.  Sex differences in response to activity-based anorexia model in C57Bl/6 mice.

Authors:  Najate Achamrah; Séverine Nobis; Alexis Goichon; Jonathan Breton; Romain Legrand; Jean Luc do Rego; Jean Claude do Rego; Pierre Déchelotte; Sergueï O Fetissov; Liliana Belmonte; Moïse Coëffier
Journal:  Physiol Behav       Date:  2016-12-12

6.  Olanzapine, but not fluoxetine, treatment increases survival in activity-based anorexia in mice.

Authors:  Stephanie J Klenotich; Mariel P Seiglie; Matthew S McMurray; Jamie D Roitman; Daniel Le Grange; Priya Dugad; Stephanie C Dulawa
Journal:  Neuropsychopharmacology       Date:  2012-03-07       Impact factor: 7.853

7.  Tetrahydro-beta-carboline micro-injected into the hippocampus induces an anxiety-like state in the rat.

Authors:  P Huttunen; R D Myers
Journal:  Pharmacol Biochem Behav       Date:  1986-06       Impact factor: 3.533

8.  Reversal of neurosteroid effects at alpha4beta2delta GABAA receptors triggers anxiety at puberty.

Authors:  Hui Shen; Qi Hua Gong; Chiye Aoki; Maoli Yuan; Yevgeniy Ruderman; Michael Dattilo; Keith Williams; Sheryl S Smith
Journal:  Nat Neurosci       Date:  2007-03-11       Impact factor: 24.884

Review 9.  Exploring exercise as an avenue for the treatment of anxiety disorders.

Authors:  Lindsey B DeBoer; Mark B Powers; Angela C Utschig; Michael W Otto; Jasper A J Smits
Journal:  Expert Rev Neurother       Date:  2012-08       Impact factor: 4.618

Review 10.  Cellular and molecular effects of steroid hormones on CNS excitability.

Authors:  Sheryl S Smith; Catherine S Woolley
Journal:  Cleve Clin J Med       Date:  2004-02       Impact factor: 2.321

View more
  3 in total

1.  Food Restriction Engages Prefrontal Corticostriatal Cells and Local Microcircuitry to Drive the Decision to Run versus Conserve Energy.

Authors:  Adrienne N Santiago; Emily A Makowicz; Muzi Du; Chiye Aoki
Journal:  Cereb Cortex       Date:  2021-05-10       Impact factor: 5.357

2.  Animal Models for Anorexia Nervosa-A Systematic Review.

Authors:  Sophie Scharner; Andreas Stengel
Journal:  Front Hum Neurosci       Date:  2021-01-20       Impact factor: 3.169

Review 3.  Rethinking the Approach to Preclinical Models of Anorexia Nervosa.

Authors:  Marie François; Lori M Zeltser
Journal:  Curr Psychiatry Rep       Date:  2022-02-11       Impact factor: 5.285

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.